Leaflet ONCASPAR 750U / ml powder for solution for injection / infusion
Indicated for: cancer
Route of administration: injectable / infusion
Substance: pegaspargase (antineoplastic agent)
ATC: L01XX24 (Antineoplastic and immunomodulating agents | Other antineoplastic agents)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Pegaspargase is an antineoplastic agent used in the treatment of acute lymphoblastic leukemia (ALL). It works by degrading asparagine, an amino acid essential for the growth of leukemic cells, thereby inhibiting their proliferation.
The medication is administered intravenously or intramuscularly, as directed by a doctor, usually as part of a combination chemotherapy regimen. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as allergic reactions, pancreatitis, or coagulation disorders. It is important to inform the doctor of any unusual symptoms.
Common side effects include allergic reactions, elevated liver enzymes, and coagulation disorders. In rare cases, severe reactions such as acute pancreatitis or thrombosis may occur. Patients should be informed of these risks before use.
General data about ONCASPAR 750U / ml
- Substance: pegaspargase
- Date of latest medicines list: 01-06-2026
- Product code: W66172001
- Concentration: 750U / ml
- Pharmaceutical form: powder for solution for injection / infusion
- Quantity: 1
- Product type: Original
- Price: 8303.23 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
